氨甲环酸未降低类风湿关节炎患者全关节置换术后输血风险
该回顾性队列研究纳入252例接受下肢全关节置换术的类风湿关节炎患者,分析术后输血危险因素。多因素分析显示基线血红蛋白降低、手术时间延长和疾病活动度升高与输血风险增加相关,而氨甲环酸使用未与输血风险降低相关。
要点
- 基线血红蛋白是类风湿关节炎患者全关节置换术后输血的主要危险因素。
- 疾病活动度升高和手术时间延长是术后输血的独立危险因素。
- 氨甲环酸使用未降低该人群术后输血风险,需前瞻性试验确认。
核心结论
- 在类风湿关节炎患者中,氨甲环酸使用未与全关节置换术后输血风险降低相关。
- 术前血红蛋白水平是术后输血的主要危险因素。
研究设计与样本
- 回顾性分析前瞻性收集的类风湿关节炎接受全关节置换术患者队列,共252例。
- 采用逻辑回归分析确定与输血相关的因素。
主要发现
- 基线血红蛋白每降低1 g/dL,输血风险增加(OR=0.394,95%CI [0.232, 0.669],P=.001)。
- 手术时间每增加1分钟,输血风险增加(OR=1.022,95%CI [1.008, 1.037],P=.003)。
- 临床疾病活动指数每增加1分,输血风险增加(OR=1.079,95%CI [1.001, 1.162])。
- 氨甲环酸使用未与术后输血风险降低相关。
关键数值与推荐
- 基线血红蛋白每降低1 g/dL与输血风险增加相关(OR=0.394,95%CI [0.232, 0.669],P=.001)。
- 手术时间每增加1分钟与输血风险增加相关(OR=1.022,95%CI [1.008, 1.037],P=.003)。
- 临床疾病活动指数每增加1分与输血风险增加相关(OR=1.079,95%CI [1.001, 1.162])。
临床怎么用
- 术前应评估并治疗类风湿关节炎患者的贫血,以优化术前健康状况。
- 应关注疾病活动度和手术时间对输血风险的影响,但二者可干预性较低。
- 当前证据不支持以降低输血风险为目的常规使用氨甲环酸,需前瞻性试验验证。
局限性
- 本研究为回顾性设计,证据等级为IV级。
- 氨甲环酸对输血风险的影响需前瞻性试验确认。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Patients with rheumatoid arthritis (RA) receive transfusions more often than patients with osteoarthritis following lower extremity total joint arthroplasty (TJA), but mitigating factors are not described. Tranexamic acid (TXA) is widely used to reduce blood loss in patients undergoing TJA, but its effect on transfusion rates in patients with RA has not been studied. METHODS: We retrospectively reviewed data from a prospectively collected cohort of patients with RA undergoing TJA. Disease activity measured by Clinical Disease Activity Index, patient-reported outcome measures, and serologies was obtained. Baseline characteristics were summarized and compared. Transfusion requirements and TXA usage were obtained from chart review. Logistic regression was used to determine factors associated with transfusion in RA patients undergoing TJA. RESULTS: The cohort included 252 patients, mostly women with longstanding RA and end-stage arthritis requiring TJA. In multivariate analysis, 1 g/dL decrease in baseline hemoglobin (odds ratio [OR] = 0.394, 95% confidence interval [CI] [0.232, 0.669], P = .001), 1-minute increase in surgical duration (OR = 1.022, 95% CI [1.008, 1.037], P = .003), and 1-point increase in Clinical Disease Activity Index (OR = 1.079, 95% CI [1.001, 1.162]) were associated with increased risk of transfusion. TXA use was not associated with decreased risk of postoperative transfusion. CONCLUSIONS: Preoperative health optimization should include assessment and treatment of anemia in RA patients before TJA, as preoperative hemoglobin level is the main risk factor for postoperative transfusion. Increased disease activity and increased surgical time were independent risk factors for postoperative transfusion but are less modifiable. While TXA did not decrease transfusion risk in this population, a prospective trial is needed to confirm this. LEVEL OF EVIDENCE: IV.
引用
- Morse KW, Heinz NK, Abolade JM, et al. Tranexamic Acid Does Not Reduce the Risk of Transfusion in Rheumatoid Arthritis Patients Undergoing Total Joint Arthroplasty. J Arthroplasty. 2020. PMID: 32423756. doi:10.1016/j.arth.2020.04.029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。